Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001383536 | SCV001582691 | pathogenic | Adrenoleukodystrophy | 2020-07-23 | criteria provided, single submitter | clinical testing | The region of the ABCD1 gene that includes exon(s) 8-10 has been determined to be clinically significant (PMID: 7581394, 20661612, Invitae). Therefore, deletions that encompass that region are likely to disrupt protein function and cause disease. This variant is a gross deletion of the genomic region encompassing exon(s) 4-10 of the ABCD1 gene. The 5' boundary is likely confined to intron 3. The 3' end of this event is unknown as it extends through the termination codon beyond the assayed region for this gene and may encompass additional genes. While this deletion is not anticipated to result in nonsense mediated decay, it is expected to create a truncated protein product or disrupt mRNA translation. This variant has not been reported in the literature in individuals with ABCD1-related conditions. For these reasons, this variant has been classified as Pathogenic. |